Q1 2016 Holdings
Filed 2016-04-19 | 92 holdings | $42.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Threshold Pharmaceuticals | COM | 885807206 | $93 | 201,537 | 0.0% |
| Bind Therapeutics Inc | COM | 05548N107 | $294 | 133,535 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $386 | 40,000 | 0.0% |
| Orexigen Therapeutics Inc | COM | 686164104 | $675 | 1,200,000 | 0.0% |
| Avalanche Biotechnologies Inc | COM | 05337G107 | $796 | 154,006 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.1K | 50,000 | 0.0% |
| Array BioPharma Inc(ARRYEUR) | COM | 04269X105 | $1.1K | 370,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $1.1K | 20,000 | 0.0% |
| Valeant Pharm Intl Inc | COM | 91911K102 | $1.3K | 50,000 | 0.0% |
| Regulus Therapeutic Inc | COM | 75915K101 | $1.4K | 200,000 | 0.0% |
| Tetraphase Pharmaceuticals Inc | COM | 88165N105 | $1.4K | 300,000 | 0.0% |
| Anthera Pharmaceuticals Inc | COM | 03674U201 | $1.6K | 435,000 | 0.0% |
| Catabasis Pharmaceuticals Inc | COM | 14875P107 | $1.7K | 345,100 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM | 766559603 | $1.8K | 850,000 | 0.0% |
| Tandem Diabetes Care Inc | COM | 875372104 | $1.8K | 209,000 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $2.1K | 266,000 | 0.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $2.1K | 60,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $2.1K | 40,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $2.1K | 105,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $2.3K | 120,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.4K | 60,000 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $2.4K | 114,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $2.5K | 40,000 | 0.0% |
| Esperion Therapeutics Inc(ESPR) | COM | 29664W105 | $2.5K | 150,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $2.6K | 500,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.6K | 64,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $2.6K | 650,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $2.7K | 200,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.7K | 82,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM | 268158201 | $2.9K | 150,000 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.0K | 170,000 | 0.0% |
| Cempra Inc | COM | 15130J109 | $3.0K | 171,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $3.0K | 600,000 | 0.0% |
| Omnicell Inc(OMCL) | COM | 68213N109 | $3.1K | 110,000 | 0.0% |
| Heartware Intl Inc | COM | 422368100 | $3.1K | 100,000 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $3.2K | 115,000 | 0.0% |
| Radius Health Inc | COM | 750469207 | $3.3K | 105,000 | 0.0% |
| Horizon Pharma Plc | COM | G4617B105 | $3.3K | 200,000 | 0.0% |
| Endologix Inc | COM | 29266S106 | $3.6K | 435,000 | 0.0% |
| Livanova Plc(LIVN) | COM | G5509L101 | $3.8K | 70,000 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $3.8K | 25,000 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $3.8K | 600,000 | 0.0% |
| Jazz Pharmaceuticals Plc(JAZZ) | SHS | G50871105 | $3.9K | 30,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $4.1K | 431,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $4.1K | 270,000 | 0.0% |
| Community Health Syst Inc(CYH) | COM | 203668108 | $4.2K | 225,000 | 0.0% |
| Regeneron Pharmaceuticals Inc(REGN) | COM | 75886F107 | $4.3K | 12,000 | 0.0% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $4.3K | 160,000 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $4.4K | 950,000 | 0.0% |
| Cerner Corp(CERNCHF) | COM | 156782104 | $4.6K | 86,000 | 0.0% |